<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05000970</url>
  </required_header>
  <id_info>
    <org_study_id>IRB 20-01947</org_study_id>
    <nct_id>NCT05000970</nct_id>
  </id_info>
  <brief_title>Telehealth Referral to Improve Outcomes</brief_title>
  <acronym>TRIO</acronym>
  <official_title>Telehealth Referral to Improve Outcomes for Asymptomatic Hypertension in the Emergency Department</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Icahn School of Medicine at Mount Sinai</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>AT&amp;T and Vital Tech</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Icahn School of Medicine at Mount Sinai</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      Emergency patients often have uncontrolled asymptomatic hypertension upon discharge from the&#xD;
      emergency department. This 3-arm randomized controlled trial will evaluate the impact of&#xD;
      nurse telehealth encounters and remote patient monitoring, using a software called Vital&#xD;
      Tech, on blood pressure control and primary care engagement.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Emergency Department (ED) clinicians encounter patients with asymptomatic hypertension (HTN)&#xD;
      on a daily basis but usually fail to intervene. This pilot study will determine the utility&#xD;
      of a novel intervention: Telehealth Referral to Improve Outcomes (TRIO), a conceptually&#xD;
      driven information technology tool focused on patients who are asymptomatic and hypertensive&#xD;
      upon ED discharge. It is designed to successfully link them to a primary care provider (PCP)&#xD;
      after ED discharge to improve blood pressure (BP) control. 48 adult ED patients who have&#xD;
      asymptomatic HTN (BP &gt;/= 140/90 mmg and &lt;/= 180/120 mmHg) and who will be discharged will be&#xD;
      enrolled in the study. This study is a single-site, 3-arm randomized controlled pilot trial.&#xD;
      All patients will receive a wireless BP monitor and tablet. Group 2 (N=16) will additionally&#xD;
      receive a telehealth consult with an RN at day 3. Group 3 (N=16) will additionally receive a&#xD;
      telehealth consult with an RN at day 3 and day 7. The research team will collect feasibility&#xD;
      outcomes: (recruitment rate, retention rate, and attrition rate of patients enrolled in TRIO&#xD;
      at 6-months and 12-months. The research team will evaluate BP control and engagement with&#xD;
      primary care at 6-months and 12-months and compare between groups.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 11, 2021</start_date>
  <completion_date type="Anticipated">October 2022</completion_date>
  <primary_completion_date type="Anticipated">October 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
    <masking_description>Both participant and investigator will be blinded on the study assignment group.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Recruitment rate</measure>
    <time_frame>6 months</time_frame>
    <description>recruitment rate of patients enrolled in TRIO at 6-months.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Recruitment rate</measure>
    <time_frame>12 months</time_frame>
    <description>recruitment rate of patients enrolled in TRIO at 12-months.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Retention rate</measure>
    <time_frame>6 months</time_frame>
    <description>retention rate of patients enrolled in TRIO at 6-months.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Retention rate</measure>
    <time_frame>12 months</time_frame>
    <description>retention rate of patients enrolled in TRIO at 12-months.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Attrition rate</measure>
    <time_frame>6 months</time_frame>
    <description>attrition rate of patients enrolled in TRIO at 6-months.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Attrition rate</measure>
    <time_frame>12 months</time_frame>
    <description>attrition rate of patients enrolled in TRIO at 12-months.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>6 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
    <time_frame>12 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participant who had follow up care</measure>
    <time_frame>6 months</time_frame>
    <description>Primary Care Engagement to be defined as having follow up care (yes/no) at 6 months</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of participant who had follow up care</measure>
    <time_frame>12 months</time_frame>
    <description>Primary Care Engagement to be defined as having follow up care (yes/no) at 12 months</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">48</enrollment>
  <condition>Hypertension</condition>
  <arm_group>
    <arm_group_label>TRIO PLUS tablet and nurse at day 3</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Virtual nurse encounter at 3 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TRIO PLUS Tablet and nurse at day 3 and 7</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Virtual nurse encounter at 3 days and 7 days</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TRIO PLUS Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>No encounter</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>blood pressure cuff PLUS tablet</intervention_name>
    <description>all arms</description>
    <arm_group_label>TRIO PLUS Group</arm_group_label>
    <arm_group_label>TRIO PLUS Tablet and nurse at day 3 and 7</arm_group_label>
    <arm_group_label>TRIO PLUS tablet and nurse at day 3</arm_group_label>
    <other_name>wireless BP monitor and tablet</other_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Telehealth Consult</intervention_name>
    <description>Telehealth consult with an RN</description>
    <arm_group_label>TRIO PLUS Tablet and nurse at day 3 and 7</arm_group_label>
    <arm_group_label>TRIO PLUS tablet and nurse at day 3</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age ≥ 18 years&#xD;
&#xD;
          -  At least two* high blood pressure readings during ED visit&#xD;
&#xD;
               1. Systolic (top #) ≥140, ≤180 AND/OR&#xD;
&#xD;
               2. Diastolic (bottom #) ≥ 90, ≤120&#xD;
&#xD;
                  *Second blood pressure may be confirmed when approaching the patient. Before&#xD;
                  approaching, check exclusions first.&#xD;
&#xD;
                  Exclusion Criteria:&#xD;
&#xD;
          -  symptomatic hypertension&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kimberly Souffront, PhD, APRN</last_name>
    <role>Principal Investigator</role>
    <affiliation>Icahn School of Medicine at Mount Sinai</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kimberly Souffront, PhD, APRN</last_name>
    <phone>212-824-8095</phone>
    <email>kimberly.souffront@mountsinai.org</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lauren Gordon, MPH</last_name>
    <email>lauren.gordon@mountsinai.org</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mount Sinai Hospital Center Emergency Dept</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10029</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Kimberly Souffront, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2021</verification_date>
  <study_first_submitted>April 28, 2021</study_first_submitted>
  <study_first_submitted_qc>August 10, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 11, 2021</study_first_posted>
  <last_update_submitted>August 10, 2021</last_update_submitted>
  <last_update_submitted_qc>August 10, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Icahn School of Medicine at Mount Sinai</investigator_affiliation>
    <investigator_full_name>Kimberly T Souffront</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Asymptomatic hypertension</keyword>
  <keyword>Referral</keyword>
  <keyword>Telehealth</keyword>
  <keyword>Remote patient monitoring</keyword>
  <keyword>Emergency Department</keyword>
  <keyword>blood pressure</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

